HAMPSBIOLTD logo

Hamps Bio Limited

HAMPSBIOLTDNSE
₹0.00▲ +0.00 (+0.00%)
Whole company worth₹22 Cr
ProfitLoss-making
1-year range₹13 – ₹29
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.

The short version

Hamps Bio, in seven plain questions.

What Hamps Bio does

Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution

Worked out from Hamps Bio's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.

01What does it do?

Hamps Bio is a micro-sized company in textile products.

Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution

Whole company is worth
₹22 crore
Shareholders
395 people
Listed since
2024

A very small company by stock-market value — prices can swing hard and trading can be thin.

02Is it growing?

Sales grew 27% last year.

There is not enough history yet to judge Hamps Bio's growth over several years.

01345Mar '25Mar '264
Point at a bar for exact figures · amounts in ₹ crore

Quarters are not all alike — many businesses sell more around festivals or year-end — so compare a quarter with the same quarter a year earlier, not the one before it.

03Does it make money?

For every ₹100 it sells, it spends ₹109.

Here is where the money from Hamps Bio's sales went in FY26, the latest full year it has reported.

₹100 of sales ends here
  1. ₹96Costs of running the businessstaff, rent, marketing, power and everything else
  2. ₹3.0Interest on its loansthe cost of borrowed money
  3. ₹9.7Wear and tearmachines, stores and buildings losing value over time
  4. ₹9Lossspent beyond what came in — covered by savings or new money

On the money its owners have put in

It lost ₹9 for every ₹100 its owners have invested.

Bank FD ~₹6–7
₹-9
₹-20₹-10₹0₹10₹20₹30₹40

Return on equity (ROE) measures the yearly profit made on the money shareholders have put into the business. Negative means the business is eating into that money.

04Is the price high or low?

Hamps Bio made a loss, so there is no "price for profit" to measure.

Investors are paying for what they hope it will earn later, not what it earns today. That makes the price harder to judge and more sensitive to news.

The share price over the past year

05Who owns it?

Its founders and parent group own 72 of every 100 shares — they control the company.

If the company were split into 100 equal shares, this is who would hold them. 395 people and institutions hold its shares.

As filed for the quarter ending 31 Mar 2026. Arrows show the change since the quarter before, in percentage points.

06What is going well, and what to watch

The figures raise more questions than they answer.

Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.

Going well

Nothing stands out in its favour in the figures we have.

Worth watching

  • Lost ₹0.7 crore in its last financial year.
  • Carries meaningful debt — ₹85 of loans for every ₹100 of shareholders' money.

07What happened lately?

Its latest quarter.

Jan–Mar 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.

Sales

₹4.5 Cr

Loss

₹0.5 Cr

No notable developments in the last few weeks.

Advanced view

Every number, every table, the full chart.

Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.

This page describes Hamps Bio using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.

Hamps Bio Limited (HAMPSBIOLTD): company summary

Hamps Bio Limited (HAMPSBIOLTD) is a micro-cap Textiles company valued at ₹22 crore operating in Textile Products on the NSE and BSE.

Hamps Bio Limited (HAMPSBIOLTD) is a micro-cap Textiles company valued at ₹22 crore operating in Textile Products on the NSE and BSE.

Financial performance
Return on equity stands at -8.8%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.74 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

More Textiles stocks · Textile Products

Hamps Bio Limited peers in Textiles

Other Textiles stocks on the NSE & BSE. See the full Textiles sector list.